Patanjali Case: Court Asks Ramdev, Balkrishna To Appear On Aug 6

Kozhikode: The case relating to ‘misleading’ advertisements of Patanjali Ayurved’s products in the media will be heard on August 6.

The Kozhikode court on Monday issued summons to Yoga guru Ramdev and his associate Acharya Balkrishna to appear before the court on this date. The order comes after the two failed to appear before the court today as directed earlier. The summons order was issued by the Kozhikode Judicial First Class Magistrate Court.

Ramdev, founder is the second accused in the case and Balkrishna is the third accused. The marketing wing of Patanjali Ayurved, Divya Pharmacy, is the first accused.

The Office of the Assistant Drugs Controller, Kozhikode lodged a complaint based on which a case was registered under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 in April.

In February, the Supreme Court had issued a contempt notice against Patanjali Ayurved and restrained it from publishing advertisements of medicines used for treatment of ailments including blood pressure, asthma, arthritis and obesity.

The first complaint against Divya Pharmacy was filed in February 2022 by KV Babu, an ophthalmologist from Kannur. He had lodged a complaint at the State Drug Control Department. Following which, the State Drug Control Department had ordered an inquiry and instances of violation of the Act surfaced.

Related Posts

  • Pharma
  • February 17, 2025
  • 94 views
GSK Pharma shares gain 20% following strong Q3FY25 results

GSK Pharma shares gained by 20 percent on Monday, February 17, as brokerages like ICICI Securities and Motilal Oswal continue to maintain positive rating of the stock. GlaxoSmithKline Pharmaceuticals Ltd…

  • Pharma
  • February 17, 2025
  • 82 views
Glenmark Pharma shares rise 4% on Q3 results, FY26 guidance

Shares of Glenmark Pharmaceuticals Ltd rose 4% on February 17 after the firm gave a strong guidance for FY26 and it returned to black in the December quarter. The drugmaker…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Wow! What a Change of Heart in Practitioners of Allopathy!

Wow! What a Change of Heart in Practitioners of Allopathy!

GSK Pharma shares gain 20% following strong Q3FY25 results

GSK Pharma shares gain 20% following strong Q3FY25 results

Glenmark Pharma shares rise 4% on Q3 results, FY26 guidance

Glenmark Pharma shares rise 4% on Q3 results, FY26 guidance

US Tariffs on pharma: What are the potential impact on Indian drugmakers

US Tariffs on pharma: What are the potential impact on Indian drugmakers

Twin Health bats a1000 before enters Digital Health NY 100

Twin Health bats a1000 before enters Digital Health NY 100

US tariff jitters rock pharma stocks; Sun Pharma, Lupin, Dr Reddy’s slump 2-4%

US tariff jitters rock pharma stocks; Sun Pharma, Lupin, Dr Reddy’s slump 2-4%